| AI | Artificial intelligence |
| BCMoC | Breast cancer metastasis-on-chip |
| BCoC | Breast cancer-on-chip |
| BCLBoC | Breast cancer liquid biopsy-on-chip |
| CAF | Cancer-associated fibroblast |
| Cas9 | CRISPR-associated protein 9 |
| CRISPR | Clustered Regularly Interspaced Short Palindromic Repeats |
| CTC | Circulating tumor cell |
| ECM | Extracellular matrix |
| EMT | Epithelial–mesenchymal transition |
| ER | Estrogen receptor |
| EV | Extracellular vesicles |
| HER2 | Epidermal growth factor receptor 2 |
| HTS | High-throughput screening |
| LNoC | Lymph node-on-chip |
| LTB | Lymph vessel-tumor tissue-blood vessel chips |
| MBC | Metastatic breast cancer |
| MDA-MB | MD Anderson-Metastatic Breast |
| NK | Natural Killer |
| OoC | Organ-on-a-chip |
| PDO | Patient-derived organoid |
| PDX | Patient-derived xenograft |
| PR | Progesterone receptor |
| TME | Tumor microenvironment |